Andrew Drakeley

ORCID: 0000-0002-8802-4706 · 11 papers in corpus
lab-animal 2025
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.202402861r

Stage-specific embryonic antigen-1 (SSEA-1)+ endometrial epithelial cells (EECs) assume the postulated stem/progenitor cell niche within the human endometrium. Previous studies have demonstrated that isolated SSEA-1+ cells have a higher cap…

review 2022
Journal of personalized medicine ·doi:10.3390/jpm12050775

Recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL), collectively referred to as recurrent reproductive failure (RRF), are both challenging conditions with many unanswered questions relating to causes and management opti…

observational 2021
International journal of molecular sciences ·doi:10.3390/ijms22083835

Recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL) are distressing conditions without effective treatments. The luminal epithelium (LE) is integral in determining receptivity of the endometrium, whereas functionalis gla…

rct 2021
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deab041

STUDY QUESTION: What is the clinical-effectiveness and safety of the endometrial scratch (ES) procedure compared to no ES, prior to usual first time in vitro fertilisation (IVF) treatment? SUMMARY ANSWER: ES was safe but did not improve pr…

observational 2021
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00725-w

Endometriosis is a common, chronic inflammatory condition, thought to have a higher incidence in symptomatic women, yet, commonly associated symptoms do not always correlate with the presence or severity of disease and diagnosis requires su…

2017
review 2012
Human Reproduction Update ·doi:10.1093/humupd/dmr049
meta-analysis 2011
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd004832.pub3

BACKGROUND: Aspirin is used to improve the outcome in women undergoing in vitro fertilisation despite inconsistent evidence of its efficacy. The most appropriate time to commence aspirin therapy and the length of treatment required are also…

meta-analysis 2007
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd004832.pub2

BACKGROUND: Low-dose aspirin is sometimes used to improve the outcome in women undergoing in vitro fertilisation, despite inconsistent evidence of efficacy and the potential risk of significant side affects. The most appropriate time to com…

2006
·doi:10.1016/j.rigapp.2006.05.008
case-report 2004
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/j.1471-0528.2004.00284.x